In addition to increased familial BC and ovarian cancer risk due to BRCA1 and BRCA2 germline mutations, approximately 40–45% of all hereditary BCs harbor BRCA1 germline mutations and 35–40% harbor BRCA2 germline mutations. The gene discussed is BRCA2; the disease is ovarian cancer.